Share on StockTwits
 

Analysts at Oppenheimer raised their price target on shares of Envision Healthcare Holdings (NASDAQ:EVHC) from $39.00 to $41.00 in a research report issued to clients and investors on Wednesday, Stock Ratings Network reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price objective would suggest a potential upside of 24.05% from the company’s current price.

Envision Healthcare Holdings (NASDAQ:EVHC) traded up 1.21% on Wednesday, hitting $33.45. 74,374 shares of the company’s stock traded hands. Envision Healthcare Holdings has a 52-week low of $24.62 and a 52-week high of $35.55. The stock has a 50-day moving average of $33.21 and a 200-day moving average of $30.10. The company has a market cap of $6.059 billion and a P/E ratio of 434.87.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks downgraded shares of Envision Healthcare Holdings from an “outperform” rating to a “neutral” rating in a research note on Tuesday, February 18th. They now have a $38.60 price target on the stock. Separately, analysts at Barclays raised their price target on shares of Envision Healthcare Holdings from $33.00 to $39.00 in a research note on Wednesday, January 8th. They now have an “overweight” rating on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $46.55.

Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.